Deep Brain Stimulation Devices Market Size to Reach USD 2,802.6 Million By 2026 at a CAGR of 15.5% - Valuates Reports

USA - English

• India - English

BANGALORE, India, March 1, 2021 /PRNewswire/ -- Deep Brain Stimulation Devices Market is Segmented by Application (Parkinson's Disease, Epilepsy, Essential Tremor, Dystonia, Obsessive Compulsive Disorder, and Others) and End User (Hospitals, Ambulatory Surgical Centers, Neurological Clinics, and Others): Opportunity Analysis and Industry Forecast, 2019–2026. This report is published on Valuates Reports in the Health Category.

The global Deep Brain Stimulation Devices Market was valued at USD 881.9 Million in 2018 and is projected to reach USD 2,802.6 Million by 2026, registering a CAGR of 15.5%.

Major factors driving the growth of deep brain stimulation devices market size are a rise in prevalence of lifestyle diseases such as depression and chronic pain, increased neurological disorders, and investment for neurological R&D. In addition, growing demand for minimally invasive surgery, acceptance of technologically advanced products, and rise in the aging population also propels the deep brain stimulation devices market growth.

Inquire For Sample: https://reports.valuates.com/request/sample/ALLI-Manu-4J34/Deep_Brain_Stimulation_Devices_Market

TRENDS INFLUENCING THE DEEP BRAIN STIMULATION DEVICE MARKET SIZE

The potential benefits of deep brain stimulation devices, such as long-term effectiveness and improved postoperative outcome management, are expected to drive the growth of deep brain stimulation device market size. These advances help clinical researchers use deep brain stimulation systems in the treatment of other neurological conditions in investigational efficacy trials.

Large patient pool suffering from Parkinson's disease, epilepsy, dystonia, and depression due to the growing geriatric population is expected to drive the growth of deep brain stimulation device market size. Deep brain stimulation devices are one of the safest and most effective devices used in surgical procedures. 

View Full Report: https://reports.valuates.com/market-reports/ALLI-Manu-4J34/deep-brain-stimulation-devices

DEEP BRAIN STIMULATION DEVICE MARKET SHARE ANALYSIS

Due to higher acceptance in surgical procedures, the dual-channel deep brain stimulation segment is expected to hold the largest deep brain stimulation device market share. One of the safest and most powerful instruments used in surgical procedures is dual deep brain stimulation devices. Therefore, the growth of the market is driven by a growing number of surgical procedures for Parkinson's disease, the prevalence of debilitating neurological disorders, and an increasing number of hospitals using dual-channel deep brain stimulation devices.

The hospital segment is expected to hold the largest deep brain stimulation market share based on end-user during the forecast period. This is due to the use of technologically advanced deep brain stimulation devices in operation theaters and intensive care units, the increasing number of deep brain stimulation surgeries, and the rising prevalence of PD.

North America is expected to hold the largest deep brain stimulation market share based on the region during the forecast period. North America's dominance is attributed to the higher number of R&D activities, presence of skilled technicians, and wide availability of technologically advanced deep brain stimulation devices. In addition, the rise in the prevalence of different neurological disorders is another factor that is boosting the region's demand for deep brain stimulation devices.

On the other hand, Asia-Pacific is expected to record the highest growth during the forecast period due to an increase in healthcare expenditure and an increase in the prevalence of different neurological disorders, such as epilepsy and others.

Inquire For Regional Reports : https://reports.valuates.com/request/regional/ALLI-Manu-4J34/Deep_Brain_Stimulation_Devices_Market

KEY MARKET SEGMENTS

Key Players:

Abbott Laboratories, Aleva Neurotherapeutics SA, Boston Scientific Corporation, Functional Neuromodulation Ltd., Beijing PINS Medical Co., Ltd., Medtronic plc, NeuroPace Inc., Nevro Corporation, and Neuronetics Inc.

By Application

• Parkinson's Disease
• Epilepsy
• Essential Tremor
• Dystonia
• Obsessive Compulsive Disorder
• Others.

By End User

• Hospitals
• Ambulatory Surgical Centers
• Neurological Clinics
• Others.

By Region

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• France
• UK
• Italy
• Rest of Europe
• Asia-Pacific
• Japan
• China
• India
• Australia
• Rest of Asia-Pacific
• LAMEA
• Brazil
• Saudi Arabia
• South Africa
• Rest of LAMEA.

Buy Now for Single User: https://reports.valuates.com/api/directpaytoken?rcode=ALLI-Manu-4J34&lic=single-user

Buy Now for Enterprise User: https://reports.valuates.com/api/directpaytoken?rcode=ALLI-Manu-4J34&lic=enterprise-license

SUBSCRIPTION

We have introduced a tailor-made subscription for our customers. Please leave a note in the Comment Section to know about our subscription plans.

SIMILAR REPORTS :

- Deep Brain Stimulation System Market by Product Type - Subthalamic DBS, Globus pallidus DBS, Thalamic DBS, Pedunculopontine nucleus DBS, Application - Parkinson's disease, Chronic pain, Depression, Obsessive-Compulsive Disorder, Tourette syndrome, Tremor, Others, by key players , by Regions: North America, Europe, China and Japan, etc.

- Deep Brain Stimulation and Service for Parkinson's Disease Market by Product Type - Single-channel DBS, Dual Channel DBS, Application - Hospitals, Specialty Clinics, by key players , by Regions: North America, Europe, China and Japan, etc.

- The global Neurostimulation Devices market was valued at USD 5372.2 Million in 2019 and is expected to reach USD 11460 Million by the end of 2026, growing at a CAGR of 11.3% during 2021-2026.

- Implantable Neurostimulation Devices Market By Product Type -  Spinal Cord Stimulation (SCS), Gastric Electrical Stimulation (GES), Deep Brain Stimulation (DBS), Sacral Nerve Stimulation (SNS), Vagus Nerve Stimulation (VNS), Other, Application - Pain Management, Parkinson's Disease, Urinary and Fecal Incontinence, Epilepsy, Gastroparesis, Other, by key players , by Regions: North America, Europe, China and Japan, etc.

- Medical simulation market size was valued at USD 1,421.1 Million in 2019, and is projected to reach USD 3,190.2 Million by 2027, growing at a CAGR of 14.6% from 2020 to 2027.

- Brain computer interface market size was valued at USD 1.36 Billion in 2019, and is projected to reach USD 3.85 Billion by 2027, growing at a CAGR of 14.3% from 2020 to 2027.

Click Here To See Related Reports On Deep Brain Stimulation Devices

ABOUT US:

Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs.

Our team of market analysts can help you select the best report covering your industry. We understand your niche region-specific requirements and that's why we offer customization of reports. With our customization in place, you can request for any particular information from a report that meets your market analysis needs.

To achieve a consistent view of the market, data is gathered from various primary and secondary sources, at each step, data triangulation methodologies are applied to reduce deviance and find a consistent view of the market. Each sample we share contains a detailed research methodology employed to generate the report. Please also reach our sales team to get the complete list of our data sources.

CONTACT US:
Valuates Reports
[email protected]
For U.S. Toll-Free Call  1-(315)-215-3225
For IST Call  +91-8040957137
WhatsApp : +91 9945648335
Website: https://reports.valuates.com
Twitter - https://twitter.com/valuatesreports
Linkedin - https://in.linkedin.com/company/valuatesreports
Facebook - https://www.facebook.com/valuatesreports

SOURCE Valuates Reports